b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30367689</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>21</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>21</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1365-2044</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>74</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Anaesthesia</Title>\n                <ISOAbbreviation>Anaesthesia</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>380-392</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.14472</ELocationID>\n            <Abstract>\n                <AbstractText>Delirium is common in intensive care patients. Dexmedetomidine is increasingly used for sedation in this setting, but its effect on delirium remains unclear. The primary aim of this review was to examine whether dexmedetomidine reduces the incidence of delirium and agitation in intensive care patients. We sought randomised clinical trials in MEDLINE, EMBASE, PubMed and CENTRAL from their inception until June 2018. Observational studies, case reports, case series and non-systematic reviews were excluded. Twenty-five trials including 3240 patients were eligible for inclusion in the data synthesis. In the patients who received dexmedetomidine (eight trials, 1425 patients), delirium was reduced, odds ratio (95%CI) 0.36 (0.26-0.51), p\xc2\xa0&lt;\xc2\xa00.001 and high quality of evidence. The use of dexmedetomidine was associated with a reduced incidence of agitation, OR (95%CI) 0.34 (0.20-0.59), p\xc2\xa0&lt;\xc2\xa00.001, moderate quality of evidence. Patients who were randomly assigned to dexmedetomidine had a significantly higher incidence of bradycardia, OR (95%CI) 2.18 (1.46-3.24), p\xc2\xa0&lt;\xc2\xa00.001, moderate quality of evidence; and hypotension, OR (95%CI) 1.89 (1.48-2.41), p\xc2\xa0&lt;\xc2\xa00.001, high quality of evidence. We found no evidence of an effect on mortality, OR (95%CI) 0.86 (0.66-1.10), p\xc2\xa0=\xc2\xa00.23, moderate quality of evidence. The trial sequential analyses for the incidence of delirium, bradycardia and hypotension was conclusive but not for the incidence of agitation and mortality. In summary, this meta-analysis suggests that dexmedetomidine reduces the incidence of delirium and agitation in intensive care patients. The general quality of evidence ranged from moderate to high.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2018 Association of Anaesthetists.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Ng</LastName>\n                    <ForeName>K T</ForeName>\n                    <Initials>KT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan University, Kuala Lumpur, Malaysia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shubash</LastName>\n                    <ForeName>C J</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chong</LastName>\n                    <ForeName>J S</ForeName>\n                    <Initials>JS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <Agency>PROSPERO</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017418">Meta-Analysis</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Anaesthesia</MedlineTA>\n            <NlmUniqueID>0370524</NlmUniqueID>\n            <ISSNLinking>0003-2409</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>67VB76HONO</RegistryNumber>\n                <NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>AIM</CitationSubset>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011595" MajorTopicYN="N">Psychomotor Agitation</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">anxiety</Keyword>\n            <Keyword MajorTopicYN="N">delirium</Keyword>\n            <Keyword MajorTopicYN="N">dexmedetomidine</Keyword>\n            <Keyword MajorTopicYN="N">intensive care units</Keyword>\n            <Keyword MajorTopicYN="N">mortality</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30367689</ArticleId>\n            <ArticleId IdType="doi">10.1111/anae.14472</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'